Literature DB >> 34626105

Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study.

Camille Mettler1, Annie-Pierre Jonville-Bera2, Aurélie Grandvuillemin3, Jean-Marc Treluyer4,5, Benjamin Terrier1,5, Laurent Chouchana4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34626105     DOI： 10.1093/rheumatology/keab756

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica.

Authors:  Anam Ahmad; Donica L Baker
Journal:  Cureus       Date:  2022-07-06

2.  A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination.

Authors:  Chenfan Xia; Rachel Edwards; Bita Omidvar
Journal:  Cureus       Date:  2022-05-27

Review 3.  Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.

Authors:  Ciro Manzo; Alberto Castagna; Marco Isetta
Journal:  Reumatologia       Date:  2022-05-18

Review 4.  Looking ahead: giant-cell arteritis in 10 years time.

Authors:  Milena Bond; Alessandro Tomelleri; Frank Buttgereit; Eric L Matteson; Christian Dejaco
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-24       Impact factor: 3.625

5.  Polymyalgia Rheumatica Following COVID-19 Vaccination.

Authors:  Akira Yokote; Shinsuke Fujioka; Nobutaka Takahashi; Takayasu Mishima; Yoshio Tsuboi
Journal:  Intern Med       Date:  2022-03-26       Impact factor: 1.282

Review 6.  Mimickers of Large Vessel Giant Cell Arteritis.

Authors:  André Ramon; Hélène Greigert; Paul Ornetti; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

7.  Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination.

Authors:  Shinji Izuka; Toshihiko Komai; Bunki Natsumoto; Hirofumi Shoda; Keishi Fujio
Journal:  Intern Med       Date:  2021-12-28       Impact factor: 1.271

8.  Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study.

Authors:  Camille Mettler; Benjamin Terrier; Jean-Marc Treluyer; Laurent Chouchana
Journal:  Rheumatology (Oxford)       Date:  2022-05-31       Impact factor: 7.046
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.